FDA NDC Directory · JSON-LD · Markdown

Topiramate

NDC 10370-368 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerEndo USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205976
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsTOPIRAMATE (200 mg/1)
Marketing started20230324
Package count2

External sources

Source: openFDA. Public-domain (CC0).